Apr. 12, 2010
Shortly after signing an agreements to establish a consumer healthcare JV in China with the Minsheng Pharmaceutical Group in late January, Sanofi-Aventis, a French pharmaceutical giant, announced on April 13, 2010 that its first R&D center in China is now operational. The company’s China R&D activities are part of its ongoing strategy which is aimed to encompass all activities, from drug-target identification to late-stage clinical studies in China.
The China center is Sanofi's third R&D center in Asia- the other two being in India and South Korea.